Guillermo
Garcia Porrero
Researcher to 2023
Hammersmith Hospital
Londres, Reino UnidoPublications in collaboration with researchers from Hammersmith Hospital (1)
2023
-
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
The Lancet. Oncology, Vol. 24, Núm. 12, pp. 1411-1422